Pro-inflammatory cytokines in autistic children in central Saudi Arabia

Neurosciences

Volumn 10, Issue 2, 2005, Pages 155-158

  Al Ayadhi, Laila Y ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASPERGER SYNDROME; AUTISM; CHILD; CONTROLLED STUDY; EATING DISORDER; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PSYCHOSOCIAL WITHDRAWAL; RETT SYNDROME; SAUDI ARABIA; SLEEP DISORDER;

EID: 18444382698     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fein D, Joy S, Green L, Waterhouse L. Autism and pervasive developmental disorders. In: Fogel B, Schiffer R, Rao S, editors. Neuropsychiatry. Baltimore (MD): Williams & Wilkins; 1996.
2. Trottier G, Srivastava L, Walker CD. Etiology of infantile autism. A review of recent advances in genetic and neurological research. J Psychiatry Neurosci 1999; 24: 103-115.
3. Cobi J, Heijren P, Philip DA. Autism and immune system. J Child Psych 1997; 38: 337-349.
4. Fiumara A, Sciotto A, Barone R, D'Asero G, Munda S, Pavone L. Peripheral lymphocyte subsets and other immune aspects in Rett syndrome. Pediatr Neurol 1999; 21: 619-621.
5. Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 2002; 45: 1-6.
6. Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001; 120: 170-179.
7. Singh VK. Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 1996; 66: 143-145.
8. Medzhitov R, Janeway Jr C. Innate immunity. N Engl J Med 2000; 343: 338-344.
9. Sabatelli M, Madia F, Mignogna T, Lippi G, Quaranta L, Tonali P. Pure motor chronic inflammatory demyelinatins polyneuropathy. J Neurol 2001; 248: 772-777.
10. Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 2002; 46: 76-84.
11. Messahel S, Pheasant AE, Pall H, Ahmed-Choudhery J, Sungum-Paliwal RS, Vostanis P. Urinary levels of neoptrin and biopterin in autism. Neurosci Lett 1998; 241: 17-20.
12. Singh VK, Warrene RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993; 7: 97-103.
13. Singh VK, Lin SX, Yang VC. Serological association of measles viruses and human herpes viruses-6 with brain autoantibodies in autism. Clin Immunol Immunopath 1998; 89: 105-108.
14. Stubbs EG, Crawford ML. Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr 1977; 7: 49-55.
15. Warrren RP, Margaretten NC, Pace NC, Foster A. Immuno abnormalities in patients with autism. J Autism Dev Disord 1986; 16: 189-197.
16. Barkhudaryan N, Dunn AJ. Molecular mechanisms of action of interleukin-6 on brain, with special reference to serotonin and the hypothalamo-pitutary- adrenaocortical axis. Neurochem Res 1999; 24: 1169-1180.
17. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pitutary-adrenal axis in severe depression. Psychiatry Res 1993; 49: 11-27.
18. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptors: A paradigm for cytokines. Science 1992; 258: 593-597.
19. Barcia C, Fernandez Barreiro A, Poza M, Herrero MT. Parkinson's disease and inflammatory changes. Neurotox Res 2003; 5: 411-418.
20. Jyonouvhi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune response in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001; 120: 170-179.
21. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 1997; 52: M201-M208.
22. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
23. Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 1992; 35: 982-984.